KLF2 exerts antifibrotic and vasoprotective effects in cirrhotic rat livers: behind the molecular mechanisms of statins (Q48246049)

9 February 2018

title

KLF2 exerts antifibrotic and vasoprotective effects in cirrhotic rat livers: behind the molecular mechanisms of statins (English)

1 reference

9 February 2018

main subject

liver cirrhosis

0 references

author

Juan Carlos García-Pagan

5

1 reference

9 February 2018

Jordi Gracia-Sancho

7

1 reference

9 February 2018

Jaime Bosch

6

object named as

Jaime Bosch

1 reference

9 February 2018

author name string

Giusi Marrone

1

1 reference

9 February 2018

Raquel Maeso-Díaz

2

1 reference

9 February 2018

Guillermo García-Cardena

3

1 reference

9 February 2018

Juan G Abraldes

4

1 reference

9 February 2018

language of work or name

English

0 references

publication date

10 December 2014

1 reference

9 February 2018

published in

Gut

1 reference

9 February 2018

volume

64

1 reference

9 February 2018

issue

9

1 reference

9 February 2018

page(s)

1434-1443

1 reference

9 February 2018

Functional aspects on the pathophysiology of portal hypertension in cirrhosis

cites work

1 reference

https://api.crossref.org/works/10.1136%2FGUTJNL-2014-308338

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FGUTJNL-2014-308338

Hepatic stellate cells: protean, multifunctional, and enigmatic cells of the liver

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FGUTJNL-2014-308338

Hepatic fibrosis: from bench to bedside

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FGUTJNL-2014-308338

Effect of HMG-CoA reductase inhibitors on proliferation and protein synthesis by rat hepatic stellate cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FGUTJNL-2014-308338

Gliotoxin stimulates the apoptosis of human and rat hepatic stellate cells and enhances the resolution of liver fibrosis in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FGUTJNL-2014-308338

Simvastatin enhances hepatic nitric oxide production and decreases the hepatic vascular tone in patients with cirrhosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FGUTJNL-2014-308338

Ascorbic acid improves the intrahepatic endothelial dysfunction of patients with cirrhosis and portal hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FGUTJNL-2014-308338

Krüppel-like factors: three fingers in many pies

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FGUTJNL-2014-308338

Endothelial expression of transcription factor Kruppel-like factor 2 and its vasoprotective target genes in the normal and cirrhotic rat liver

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FGUTJNL-2014-308338

The transcription factor KLF2 mediates hepatic endothelial protection and paracrine endothelial-stellate cell deactivation induced by statins

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FGUTJNL-2014-308338

Simvastatin ameliorates liver fibrosis via mediating nitric oxide synthase in rats with non-alcoholic steatohepatitis-related liver fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FGUTJNL-2014-308338

The therapeutic effects of bone marrow-derived mesenchymal stem cells and simvastatin in a rat model of liver fibrosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FGUTJNL-2014-308338

KLF2 Is a novel transcriptional regulator of endothelial proinflammatory activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FGUTJNL-2014-308338

Flow cessation triggers endothelial dysfunction during organ cold storage conditions: strategies for pharmacologic intervention

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FGUTJNL-2014-308338

Interaction between NO and COX pathways modulating hepatic endothelial cells from control and cirrhotic rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FGUTJNL-2014-308338

A novel modular bioreactor to in vitro study the hepatic sinusoid

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FGUTJNL-2014-308338

Leptin receptor blockade reduces intrahepatic vascular resistance and portal pressure in an experimental model of rat liver cirrhosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FGUTJNL-2014-308338

Resveratrol improves intrahepatic endothelial dysfunction and reduces hepatic fibrosis and portal pressure in cirrhotic rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FGUTJNL-2014-308338

Addition of simvastatin to cold storage solution prevents endothelial dysfunction in explanted rat livers.

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FGUTJNL-2014-308338

Hedgehog signalling regulates liver sinusoidal endothelial cell capillarisation

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FGUTJNL-2014-308338

Kruppel-like factor 4 abrogates myocardin-induced activation of smooth muscle gene expression.

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FGUTJNL-2014-308338

Reduced hepatic stellate cell expression of Kruppel-like factor 6 tumor suppressor isoforms amplifies fibrosis during acute and chronic rodent liver injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FGUTJNL-2014-308338

A network of Krüppel-like Factors (Klfs). Klf8 is repressed by Klf3 and activated by Klf1 in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FGUTJNL-2014-308338

Atorvastatin lowers portal pressure in cirrhotic rats by inhibition of RhoA/Rho-kinase and activation of endothelial nitric oxide synthase

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FGUTJNL-2014-308338

Atorvastatin attenuates hepatic fibrosis in rats after bile duct ligation via decreased turnover of hepatic stellate cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FGUTJNL-2014-308338

NF-kappaB at the crossroads of life and death

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FGUTJNL-2014-308338

Curcumin protects the rat liver from CCl4-caused injury and fibrogenesis by attenuating oxidative stress and suppressing inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FGUTJNL-2014-308338

Rat liver sinusoidal endothelial cell phenotype is maintained by paracrine and autocrine regulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FGUTJNL-2014-308338

Macrophage activation and polarization

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FGUTJNL-2014-308338

Simvastatin activates Keap1/Nrf2 signaling in rat liver

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FGUTJNL-2014-308338

The Nrf2 transcription factor protects from toxin-induced liver injury and fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FGUTJNL-2014-308338

KLF2 primes the antioxidant transcription factor Nrf2 for activation in endothelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FGUTJNL-2014-308338

Increased oxidative stress in cirrhotic rat livers: A potential mechanism contributing to reduced nitric oxide bioavailability.

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FGUTJNL-2014-308338

Simvastatin maintains function and viability of steatotic rat livers procured for transplantation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FGUTJNL-2014-308338

Effects of simvastatin administration on rodents with lipopolysaccharide-induced liver microvascular dysfunction

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FGUTJNL-2014-308338

Krüppel-like factor 2 promotes liver steatosis through upregulation of CD36.

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FGUTJNL-2014-308338

Simvastatin treatment improves liver sinusoidal endothelial dysfunction in CCl4 cirrhotic rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FGUTJNL-2014-308338

10.1136/GUTJNL-2014-308338

21 January 2018

Identifiers

DOI

1 reference

9 February 2018

1 reference

9 February 2018